A comparative analysis of tuberculosis < em > in vitro < /em > screening in pemphigus patients selected for treatment with rituximab

CONCLUSIONS: Prior immunosuppression and autoimmunity might be the cause of indefinite test results, but they do not seem to increase positive results. In the native population, the QFT-Plus screening reveals a significant population exposure to M. tuberculosis infection independent of pemphigus autoimmunity, and such screening can be a starting point for identifying patients requiring anti-tuberculosis drug prophylaxis before combined RTX-glucocorticosteroid treatment.PMID:34658703 | PMC:PMC8501442 | DOI:10.5114/ada.2021.108904
Source: Advances in Dermatology and Allergology - Category: Dermatology Authors: Source Type: research